相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Extensively drug-resistant tuberculosis
Mandeep Jassal et al.
LANCET INFECTIOUS DISEASES (2009)
Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism
Fernanda S. Spies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Treatment outcomes in extensively resistant tuberculosis
Edward D. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Emergence of Extensive Drug Resistance during Treatment for Multidrug-Resistant Tuberculosis
Helen S. Cox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
Manormoney Pillay et al.
CLINICAL INFECTIOUS DISEASES (2007)
Mutations in rsmG, encoding a 16S rRNA methyltransferase, result in low-level streptomycin resistance and antibiotic overproduction in Streptomyces coelicolor A3(2)
Kenji Nishimura et al.
JOURNAL OF BACTERIOLOGY (2007)
Extensively drug-resistant tuberculosis, Italy and Germany
Giovanni Battista Migliori et al.
EMERGING INFECTIOUS DISEASES (2007)
Worldwide emergence of extensively drug-resistant tuberculosis
N. Sarita Shah et al.
EMERGING INFECTIOUS DISEASES (2007)
Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria
Susumu Okamoto et al.
MOLECULAR MICROBIOLOGY (2007)
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets
Lynn G. Dover et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
Neel R. Gandhi et al.
LANCET (2006)
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobactetium tuberculosis
Manzour Hernando Hazbon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Molecular characteristics and global spread of mycobacterium tuberculosis with a Western Cape F11 genotype
TC Victor et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Modeling epidemics of multidrug-resistant M-tuberculosis of heterogeneous fitness
T Cohen et al.
NATURE MEDICINE (2004)
Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells
I Matsunaga et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Versatile and open software for comparing large genomes
S Kurtz et al.
GENOME BIOLOGY (2004)
ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates
GP Morlock et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans
AS Pym et al.
INFECTION AND IMMUNITY (2002)
Crystal structure of the Escherichia coli glucose-inhibited division protein B (GidB) reveals a methyltransferase fold
MJ Romanowski et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2002)
Evolution of drug resistance in Mycobacterium tuberculosis:: Clinical and molecular perspective
SH Gillespie
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
IS6110 insertions in Mycobacterium tuberculosis:: Predominantly into coding regions
S Sampson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Molecular evidence for independent occurrence of IS6110 insertions at the same sites of the genome of Mycobacterium tuberculosis in different clinical isolates
Z Fang et al.
JOURNAL OF BACTERIOLOGY (2001)